Post by i-Pharm GxP

US Life Sciences manufacturing investment hit $582B+ in pledges in 2025. But the more interesting question was always where it would land. In December, we covered the surge and the companies driving it. This month, we're looking at something different: the states that haven’t traditionally been part of that conversation, and now are.   Four of them in particular stand out. Read this month's GxP Insights to find out which 👇   --- Want more insights like this? ✅ Subscribe to GxP Insights for monthly deep dives into key topics across Medical Devices, Biologics, Cell & Gene Therapy, and Sterile/Aseptic Manufacturing ✅ Follow i-Pharm GxP for regular opportunities, industry updates, and insights across Life Sciences capital projects. #LifeSciencesTrends #Pharma #GMP #Manufacturing #Biologics